And so that’s why the campaign builder is taking off. And we did announce another client today. It’s a large multi-specialty group practice that has Medicare Medicaid, Medicare Advantage, Medicaid, NACA in it. And so we will put that to the test as we implement that product. As far as the full platform being available, that is the work that Mario and I are now starting to work on in evaluating what we need to do to harden the platform. We have some new technology coming out on the back end that we are very confident in. But until we know that it works front to back, the whole platform won’t be available, but we’ll roll it out in pieces where we find it valuable for our clients.
Operator: Our next question is Kevin Fischbeck, Bank of America.
Unidentified Analyst: Hey. This is (ph) on for Kevin Fischbeck. So maybe sort of shifting topics a bit. How are you guys thinking about MLR, sorry, not MLR, Medicaid redeterminations? I mean, of what impact that could have to your membership. What’s that risk pool look like? But the new people getting on the exchanges, do you think they’ll have a higher, like, a lower MLR in the quarter? And kind of along the lines of smaller groups, how is your CI +Oscar going? Sort of what traction are you seeing in small group market?
Sid Sankaran: Great. Thanks, John. It’s Sid. I’ll take that. You know, I think as a reminder, we’ve mentioned before, we expect relatively deminimus impact from Medicaid redetermination in our 2023 estimates. And we have said we do think these members will be higher acuity than our current population. As of today, the majority of our states are now live, but still early in the Medicaid redetermination process. And we’ve been monitoring our book and haven’t seen anything meaningful in the trends yet. But pulling up, I mean, we believe the ACA has many tailwinds to long term growth, including Medicaid redetermination over the next few years. And we have a larger market with an appropriate risk pool and Oscar will be very differentiated in delivering service to its members.
So in the long run, we think that’ll be a good fit. With respect to your second question, I think (ph), with respect to our small group joint venture. I think similar to the theme you heard from us before, we approached 2023 pricing with the balance of growth and profitability. We continue to see balanced growth across our markets, Georgia, Arizona, in particular. But of course, we’re targeting profitable growth here and we’re going to continue to target good retention and have real investments in our member and broker experience.
Mark T. Bertolini: One of the opportunities, Kevin, we’re investigating is (ph) and the potential to grow the individual market through moving small group and middle market off of employer sponsored into (ph) coverage. And we’re the beginnings of that analysis. We see a lot of promise. When you look at the insured premium in the marketplace, insured premium is almost 70% individual when you look at Medicare Medicaid and ACA, and there’s more opportunity for us to grow that market over time. And so we will be taking a hard look at that this year and looking at a potential launch next year.
Unidentified Analyst: Alright. Great. Thanks. See you guys tomorrow.
Mark T. Bertolini: Yep. See you tomorrow.
Operator: And we’ll now hear from Nathan Rich, Goldman Sachs.
Nathan Rich: Hi, good afternoon. Thanks for the questions. I guess when we think about getting to profitability for the total business by 2024. I guess how are you thinking at a high level about the algorithm to do that between growth of the market and kind of leverage on that growth as you grow in line or above the market versus taking additional actions like exiting California. And are you considering any other re-evaluations of the footprint as you think about the markets that you want to be in going forward? Thank you.
